166 related articles for article (PubMed ID: 2505290)
21. NMDA receptors modulate long-term habituation to spatial novelty: dose- and genotype-dependent differential effects of posttrial MK-801 and CPP in rats.
Pellicano MP; Siciliano F; Sadile AG
Physiol Behav; 1993 Sep; 54(3):563-8. PubMed ID: 8415951
[TBL] [Abstract][Full Text] [Related]
22. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.
Sato K; Morimoto K; Okamoto M
Brain Res; 1988 Oct; 463(1):12-20. PubMed ID: 2848606
[TBL] [Abstract][Full Text] [Related]
23. Respiratory effects of the N-methyl-D-aspartate (NMDA) antagonist, MK-801, in intact and vagotomized chronic cats.
Foutz AS; Champagnat J; Denavit-Saubié M
Eur J Pharmacol; 1988 Sep; 154(2):179-84. PubMed ID: 3068062
[TBL] [Abstract][Full Text] [Related]
24. Effects of the NMDA antagonists CPP and MK-801 on delayed conditional discrimination.
Tan S; Kirk RC; Abraham WC; McNaughton N
Psychopharmacology (Berl); 1989; 98(4):556-60. PubMed ID: 2505299
[TBL] [Abstract][Full Text] [Related]
25. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
Koek W; Woods JH; Winger GD
J Pharmacol Exp Ther; 1988 Jun; 245(3):969-74. PubMed ID: 2838610
[TBL] [Abstract][Full Text] [Related]
26. Post-lesion administration of the NMDA receptor antagonist MK-801 does not impair motor recovery after unilateral sensorimotor cortex injury in the rat.
Goldstein LB; Coviello A
Brain Res; 1992 May; 580(1-2):129-36. PubMed ID: 1387033
[TBL] [Abstract][Full Text] [Related]
27. Long-term D1-dopamine receptor sensitization in neonatal 6-OHDA-lesioned rats is blocked by an NMDA antagonist.
Criswell HE; Mueller RA; Breese GR
Brain Res; 1990 Apr; 512(2):284-90. PubMed ID: 2162235
[TBL] [Abstract][Full Text] [Related]
28. Effect of the noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 on food-anticipatory activity rhythm in the rat.
Ono M; Shibata S; Minamoto Y; Watanabe S
Physiol Behav; 1996; 59(4-5):585-9. PubMed ID: 8778838
[TBL] [Abstract][Full Text] [Related]
29. Low dose of 1,3-di(2-tolyl)guanidine (DTG) attenuates MK-801-induced spatial working memory impairment in mice.
Maurice T; Hiramatsu M; Itoh J; Kameyama T; Hasegawa T; Nabeshima T
Psychopharmacology (Berl); 1994 Apr; 114(3):520-2. PubMed ID: 7855212
[TBL] [Abstract][Full Text] [Related]
30. Differential effect of ketamine on the reference and working memory versions of the Morris water maze task.
Wesierska M; Macias-Gonzalez R; Bures J
Behav Neurosci; 1990 Feb; 104(1):74-83. PubMed ID: 2156524
[TBL] [Abstract][Full Text] [Related]
31. Phencyclidine-like discriminative stimulus properties of MK-801 in rats.
Willetts J; Balster RL
Eur J Pharmacol; 1988 Jan; 146(1):167-9. PubMed ID: 3280331
[TBL] [Abstract][Full Text] [Related]
32. Disruption of central cholinergic systems in the rat by basal forebrain lesions or atropine: effects on feeding, sensorimotor behaviour, locomotor activity and spatial navigation.
Whishaw IQ; O'Connor WT; Dunnett SB
Behav Brain Res; 1985; 17(2):103-15. PubMed ID: 4074488
[TBL] [Abstract][Full Text] [Related]
33. The effect of the NMDA receptor antagonist, MK-801, on the course and outcome of kindling.
Mintz M; Rose IC; Herberg LJ
Pharmacol Biochem Behav; 1990 Apr; 35(4):815-21. PubMed ID: 2161108
[TBL] [Abstract][Full Text] [Related]
34. The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats.
Layer RT; Kaddis FG; Wallace LJ
Pharmacol Biochem Behav; 1993 Jan; 44(1):245-7. PubMed ID: 8430127
[TBL] [Abstract][Full Text] [Related]
35. Maturation of the hypothalamic control of pulsatile gonadotropin-releasing hormone secretion at onset of puberty. I. Increased activation of N-methyl-D-aspartate receptors.
Bourguignon JP; Gerard A; Mathieu J; Mathieu A; Franchimont P
Endocrinology; 1990 Aug; 127(2):873-81. PubMed ID: 2164923
[TBL] [Abstract][Full Text] [Related]
36. Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801.
Karler R; Calder LD; Chaudhry IA; Turkanis SA
Life Sci; 1989; 45(7):599-606. PubMed ID: 2671566
[TBL] [Abstract][Full Text] [Related]
37. NMDA receptor antagonism impairs reversal learning in developing rats.
Chadman KK; Watson DJ; Stanton ME
Behav Neurosci; 2006 Oct; 120(5):1071-83. PubMed ID: 17014258
[TBL] [Abstract][Full Text] [Related]
38. Anticonvulsant actions of MK-801 on the lithium-pilocarpine model of status epilepticus in rats.
Ormandy GC; Jope RS; Snead OC
Exp Neurol; 1989 Nov; 106(2):172-80. PubMed ID: 2553470
[TBL] [Abstract][Full Text] [Related]
39. Systematic studies on the effects of the NMDA receptor antagonist MK-801 on cerebral blood flow and responsivity, EEG, and blood-brain barrier following complete reversible cerebral ischemia.
Stevens MK; Yaksh TL
J Cereb Blood Flow Metab; 1990 Jan; 10(1):77-88. PubMed ID: 2153692
[TBL] [Abstract][Full Text] [Related]
40. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
Irifune M; Shimizu T; Nomoto M; Fukuda T
Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
